1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

McNeil Remediation Stretches Out, Dragging On J&J Consumer Sales

 
• By Dan Schiff

The latest delay in Johnson & Johnson’s remediation of its McNeil OTC manufacturing pushes back FDA’s review of the Fort Washington, Pa., facility to “late 2013.” The firm’s Q1 results saw the worldwide consumer business fall 2.4% to $3.60 billion, including negative currency exchange effects.

Johnson & Johnson continues nudging back the timetable for returning its OTC division to full strength, revealing that about 50% of the products recalled in 2009 and 2010 will not return until 2013.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America